HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge, 50 mL syringe (0.2 mg/mL), Rx Only, SSM Health ...

FDA Drug Recall #D-0776-2023 — Class II — May 9, 2023

Recall Summary

Recall Number D-0776-2023
Classification Class II — Moderate risk
Date Initiated May 9, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm SSM Health Care St. Louis DBA SSM St. Clare Health Center
Location Fenton, MO
Product Type Drugs
Quantity 3,232 syringes

Product Description

HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge, 50 mL syringe (0.2 mg/mL), Rx Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394. NDC: 60652-0600-2

Reason for Recall

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Distribution Pattern

Product was distributed in Missouri.

Lot / Code Information

Lot #: 20230222-45AB24, BUD: 8/21/2023; Lot #: 20230110-058361, BUD: 7/9/2023; Lot #: 20221208-0F5483, BUD: 6/6/2023; Lot #: 20221109-45BA60, BUD: 5/8/2023; Lot #:20220929-523FD5, BUD: 3/28/2023; Lot#: 20220914-5D5AE0, BUD: 3/13/2023; Lot #: 220502-024, BUD: 10/29/2022; Lot #: 220510-035, BUD: 11/6/2022; Lot #: 220526-015, BUD: 11/22/2022; Lot#: 220811-010, BUD: 2/7/2023

Other Recalls from SSM Health Care St. Louis DBA SSM St....

Recall # Classification Product Date
D-0436-2024 Class II FentaNYL citrate, 10 mcg in 0.9% Sodium Chlorid... Feb 29, 2024
D-0435-2024 Class II Phenylephrine HCl, 1000 mcg/10 mL, 10 mL Total ... Feb 29, 2024
D-0007-2022 Class II Potassium Chloride 40 mEq in 0.9% Sodium Chlori... Sep 22, 2021
D-0143-2018 Class II Oxytocin 30 units in 0.9% Sodium Chloride 500 m... Aug 10, 2017
D-0145-2018 Class II Succinylcholine chloride 100 mg in 5 mL syringe... Aug 10, 2017

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.